Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Avandia (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 21
» View wsbtradio.com items only
    Jun 6, 2013 |Story| Reuters

  1. PRESS DIGEST - Wall Street Journal - June 7

    Reuters
    June 7 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. * The National Security Agency's monitoring of Americans includes customer records from the...

    Tags: United Kingdom, Computer Crime, Chemical Industry, Labor Legislation, Career and Workplace

    2. Jun 7, 2013 |Story| Aberdeen News

  2. FDA panel favors easing safety limits on diabetes pill

    WASHINGTON - Federal health experts are recommending changes to safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis suggesting that the drug may not increase the risk of heart attack as much as previously thought....

    Tags: Takeda Pharmaceutical Company Limited, Health and Safety at School, Elections, Food and Drug Administration, Medical Research

    3. Jun 6, 2013 |Story| Los Angeles Times

  3. FDA panel recommends continued Avandia sales, with restrictions

    An advisory panel to the Food and Drug Administration on Thursday voted to keep the diabetes drug Avandia on the market with a slate of restrictions on its use, and suggested that although evidence of the drug's safety problems may have been overblown, Avandia's days as a blockbuster diabetes medication are probably behind it.
    An advisory panel to the Food and Drug Administration on Thursday voted to keep the diabetes drug Avandia on the market with a slate of restrictions on its use, and suggested that although evidence of the drug's safety problems may have been overblown,...

    Tags: Trials, Science and Technology, Elections, Diabetes, Heart Attack

    4. Jun 2, 2013 |Story| Reuters

  4. PRESS DIGEST-New York Times business news - June 3

    Reuters
    June 3 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. * Government officials, drug companies and medical experts are considering options...

    Tags: Book, Smithfield Foods, Food and Drug Administration, GlaxoSmithKline PLC, The New York Times

    5. Jun 5, 2013 |Story| Los Angeles Times

  5. Avandia review by FDA examines whether dangers were overdrawn

    Three years after the Food and Drug Administration was taken to task for overlooking safety problems with the diabetes drug Avandia, a panel of FDA advisors met Wednesday to open a two-day review of the research that guided the agency's actions.
    Three years after the Food and Drug Administration was taken to task for overlooking safety problems with the diabetes drug Avandia, a panel of FDA advisors met Wednesday to open a two-day review of the research that guided the agency's actions. The...

    Tags: Healthcare Provider, Science and Technology, Medical Research, Chemical Industry, Trials

    6. Mar 25, 2013 |Story| Los Angeles Times

  6. Girardi | Keese

    Given its deep bench of skilled trial attorneys—who include partner Amy Fisch Solomon —Girardi | Keese has pioneered litigation in the personal injury field, achieving more than $10 billion for its injured clients. “Amy is truly one of...

    Tags: Vioxx (drug), Lawyers, Justice System, Actos (drug), Yasmin (drug)

    7. Feb 20, 2013 |Story| Baltimore Sun

  7. State AG sues maker of diabetes drugs for false advertising

    Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market.
    Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...

    Tags: Justice System, Douglas F. Gansler, Crime, Law and Justice, Trials, Chemical Industry

    8. Aug 1, 2012 |Story| Chicago Tribune

  8. What drugs are going generic this year and next

    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic Pharmaceutical Association.
    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic...

    Tags: Bipolar Disorder, Fosamax (drug), HIV, Symptoms, Diabetes

    9. Jul 2, 2012 |Story| WPMT-LTV

  9. Pennsylvania to receive more than $13 million as part of GlaxoSmithKline healthcare fraud settlement

    Attorney General Linda Kelly today announced that Pennsylvania will receive more than $13 million as part of the largest healthcare fraud settlement in United States history.
    Assistant Press Secretary
    Attorney General Linda Kelly today announced that Pennsylvania will receive more than $13 million as part of the largest healthcare fraud settlement in United States history. Kelly said that GlaxoSmithKline, a British based pharmaceutical company that...

    Tags: Bipolar Disorder, Health Insurance, Sexual Dysfunction, Shingles, Diabetes

    10. Jul 2, 2012 |Story| Los Angeles Times

  10. GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says

    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil, Wellbutrin and Advair, the U.S. government announced.
    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...

    Tags: Criminals, Bribery, Sexual Dysfunction, Trials, Corporate Crime

    11. Feb 7, 2011 |Story| Reuters

  11. Glaxo adds safety restrictions to Avandia label

    WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack.
    Reuters
    WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration...

    Tags: Takeda Pharmaceutical Company Limited, Health Organizations, European Union, IMS Health Incorporated, Chemical Industry

    12. Sep 24, 2010 |Resource Link| Health Portal

  12. Government information about Avandia

    Tags: Pharmaceuticals

 1  2 • Next >
Original site for Avandia (drug) topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Avandia (drug) Photos
After issuing safety warnings to diabetics taking the b...
(June 5, 2013)
Avandia FDA review
The controversial diabetes drug Avandia will no longer...
(May 19, 2011)
FDA to limit availability of diabetes drug Avandia
6: The FDA said in September that it would sharply limi...
(October 20, 2010)
FDA limits access to Avandia